Maximize Savings and Maintain Compliance
The 340B Drug Pricing Program administered by Health Resources and Services Administration (HRSA), enables eligible hospitals to save an average of 25% to 50% on pharmaceutical purchases, offering significant financial relief. However, increased regulatory scrutiny from HRSA and other changes at the federal level makes strict compliance essential to maintain these benefits. Microscope’s 340B team of pharmacists, technicians and financial professionals help hospitals navigate these challenges by providing independent audits, compliance testing, and expert guidance and education, ensuring they continue to meet all regulatory requirements outlined by HRSA.
Strategic Optimization and Compliance of 340B Program Resources
By optimizing 340B savings while maintaining compliance, hospitals can reinvest those savings into critical patient care and services for vulnerable populations. Our comprehensive approach helps hospitals not only adhere to regulations but also maximize the financial opportunities available through the 340B Program which requires a strategic approach. Microscope works with hospitals to identify areas where additional savings can be achieved and resources optimized, ensuring that your hospital is fully leveraging the program.
Our areas of focus include:
Stay Ahead of Regulatory Changes
Regulatory requirements for the 340B Program are constantly evolving, and staying ahead of these changes is critical for maintaining compliance and optimizing savings. Microscope’s team of clinical and financial experts keeps you informed of the latest regulatory updates and provides the support you need to mitigate risk and adjust your 340B Program operations accordingly. With a proactive approach to optimization and compliance, Microscope empowers your hospital to focus on what matters most: delivering high-quality care to your patients.